Boyd Watterson Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7K Hold
56
0.01% 241
2026
Q1
$16.4K Hold
56
0.01% 257
2025
Q4
$19.6K Hold
56
0.01% 249
2025
Q3
$18.1K Hold
56
0.01% 247
2025
Q2
$21.8K Hold
56
0.01% 242
2025
Q1
$24.4K Hold
56
0.01% 245
2024
Q4
$20.7K Hold
56
0.01% 260
2024
Q3
$29.1K Hold
56
0.01% 224
2024
Q2
$30.3K Hold
56
0.01% 222
2024
Q1
$29K Hold
56
0.01% 226
2023
Q4
$26.4K Hold
56
0.01% 236
2023
Q3
$24.4K Hold
56
0.01% 233
2023
Q2
$24.9K Hold
56
0.01% 237
2023
Q1
$25.7K Hold
56
0.01% 238
2022
Q4
$28.7K Buy
+56
New +$28.4K 0.01% 225

Other funds holding ELV

Boyd Watterson Asset Management's ELV Position: Q2 2026 in Review

Boyd Watterson Asset Management held its Elevance Health (ELV) position steady in Q2 2026 at 56 shares worth $21.7K. The position accounts for 0.01% of the portfolio, ranked #241.

Boyd Watterson Asset Management first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. The position peaked at $30.3K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Boyd Watterson Asset Management held 56 shares of Elevance Health worth $21.7K as of Q2 2026.
  • Boyd Watterson Asset Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.01% of Boyd Watterson Asset Management's portfolio in Q2 2026, its #241 holding.
  • Boyd Watterson Asset Management first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
  • Boyd Watterson Asset Management's Elevance Health position peaked at $30.3K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Boyd Watterson Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.